Today, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) announced the launch of ‘Cuida tu Don,’ a national public awareness initiative featuring legendary entertainer Mario Kreutzberger, better known as ‘Don Francisco.’ Kreutzberger, who has type 2 diabetes, will serve as an ambassador for the initiative and encourage Hispanics with type 2 diabetes to live a lifestyle conducive to staying healthy. ‘Cuida tu Don,’ translated as ‘Take Care of Your Gift,’ is designed to engage, educate and inspire Hispanics with type 2 diabetes and their families. The initiative provides resources and information in three key aspects of diabetes – nutrition, fitness and treatment options – to the estimated 3.2 million Hispanics in the United States with the disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7401451-boehringer-ingelheim-diabetes/
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
All of us should be concerned with our bone density. Strong bones will make your life healthier and disease free as you age. Discover a few foods that are important for preventing osteoporosis.
This year, Bob Evans Farms is partnering with JDRF for the second year, with a goal of raising $100,000 for T1D research by selling JDRF’s signature paper sneakers in each of its 561 restaurants.
Starting today through March 19, guests can support the fight against T1D by making donations of their choice to JDRF at their local Bob Evans restaurant. Guests interested in making a contribution will receive one of JDRF’s paper sneakers to sign and display. In addition, on March 19, Bob Evans will host a national community fundraiser, donating 15 percent of sales to JDRF when guests present a fundraising flyer. To access and download the community fundraiser flyer, visit Bob Evans’ Curing Diabetes Facebook page.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65919-bob-evans-farms-fight-against-type-1-diabetes-t1d-jdrf-partnership
Every year, more than 55,000 people around the world die from rabies. In response, nearly 20 million dogs are needlessly and cruelly killed in misguided attempts to control the disease. Today, on World Rabies Day, the World Society for the Protection of Animals (WSPA) is calling for “Collars Not Cruelty” and asking governments worldwide to tackle rabies through the only humane and effective solution: mass vaccination of dogs.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52354-wspa-demands-collars-not-cruelty-fight-against-rabies-global-campaign
In honor of World Pancreatic Cancer Day on Nov. 16, people around the world will come together to Demand Better in the fight against the world’s toughest cancer, starting with earlier diagnosis. The annual one-day campaign is an initiative of the World Pancreatic Cancer Coalition, which is comprised of more than 60 organizations from 27 countries on six continents.
Every day, more than 1,000 people worldwide will be diagnosed with pancreatic cancer. Of that, an estimated 985 will die from the disease. Additionally, pancreatic cancer has the lowest survival rate among all major cancers, and in nearly every country, it is the only major cancer with a single-digit five-year survival rate (2-9 percent). These stunning figures are not merely statistics, they represent family members, friends and colleagues on every corner of the globe.
“This year, we are turning World Pancreatic Cancer Day from a day of awareness to a day of action,” said Julie Fleshman, JD, MBA, World Pancreatic Cancer Coalition chair. “As we expand our global movement to end pancreatic cancer, we are demanding better for pancreatic cancer patients now and in the future.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8201651-world-pancreatic-cancer-day-demand-better/
www.bms-onkologie.de ist die unternehmensbezogene „Heimat“ von Bristol-Myers Squibb Onkologie und bietet für Fachkreise und Öffentlichkeit seit September 2011 neben einem Einblick in Forschung und Entwicklung auch Aktuelles zu verschiedenen onkologischen Erkrankungen. Herzstück ist eine Mediathek mit multimedialen Inhalten unterteilt in „News“, „Veröffentlichungen“, „Veranstaltungen“ und „Austausch“.
www.melanom-wissen.de ist eine Disease Awareness Website zum Thema Melanom (Schwarzer Hautkrebs). Sie bietet Interessierten umfassende Hinweise zu Risikofaktoren und Prävention sowie hilfreiche Informationen und Serviceangebote nach Diagnosestellung.
http://multivu.prnewswire.com/mnr/prne/bristolmyers/52774/
Jewelry Television (JTV) is excited to once again join Go Red For Women® in February to support the fight against heart disease. The national jewelry retailer and broadcast network will promote a ‘Love Your Heart’ comprehensive multimedia campaign to increase awareness and educate viewers about the risks of heart disease and to raise funds for the American Heart Association’s Go Red For Women® movement.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7372631-jewelry-television/
In celebration of National Recovery Month, American Addiction Centers (AAC) announced today the launch of a nationwide campaign, 5 Misconceptions About Recovery: What We’ve Learned from Addiction Experts and Those in Recovery, to educate the public on the complexity of sobriety. The campaign also provides a comprehensive toolkit, which includes information on the stages of relapse, ways to support a loved one in recovery as well as a free paperback copy of CEO, Michael Cartwright’s book, Believable Hope.
To view the multimedia release go to:
https://www.multivu.com/players/English/8215651-american-addiction-centers-misconceptions-recovery-month/
After learning that more than 80 million Americans are living with heart disease, Mrs. Claus decided it was time that she and Santa make a change. She now creates a daily regimen for the Claus household filled with heart healthy meals and activities, including, of course, milk fortified with omega-3s and joining in the reindeer games.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7183432-heart-healthier-holiday-dsm/
An international team of researchers led by Gerard D. Schellenberg, PhD, a member of the CurePSP Genetics Consortium and professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has identified three new genes that can increase the risk of people developing Progressive Supranuclear Palsy (PSP).
PSP is a rare neurodegenerative brain disease, similar to Parkinson’s disease, which causes severe disability by destroying parts of cells that allow the brain to function normally. While PSP has underlying biological similarities to Alzheimer’s disease, a disease which primarily affects memory, PSP impacts a person’s physical movement and bodily functions. PSP leads to progressive decline in patients — there is no known cause or cure.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/psp/49958/
